Literature DB >> 33171470

Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm.

Kamran Shadvar1, Ali Tagizadiyeh2, Ali Akbar Gamari1, Hassan Soleimanpour3, Ata Mahmoodpoor4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33171470     DOI： 10.1159/000511391

Source DB:  PubMed          Journal:  Blood Purif        ISSN： 0253-5068            Impact factor:   2.614


× No keyword cloud information.
  4 in total

1.  The causal relationship between circulating cytokines and critically ill COVID-19: A bidirectional Mendelian randomization analysis.

Authors:  Yu Yang; Yang Xiaohui; Sui Miao; Zhong Yingshuo
Journal:  J Glob Health       Date:  2022-02-19       Impact factor: 4.413

2.  The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study.

Authors:  Karjbundid Surasit; Nattachai Srisawat
Journal:  Blood Purif       Date:  2022-02-09       Impact factor: 2.614

3.  Efficacy of Hemoperfusion in Severe and Critical Cases of COVID-19.

Authors:  Ilad Alavi Darazam; Muhanna Kazempour; Mohamad Amin Pourhoseingholi; Firouze Hatami; Mohammad Mahdi Rabiei; Farid Javandoust Gharehbagh; Mahdi Amirdosara; Mohammadreza Hajiesmaeili; Minoosh Shabani; Shervin Shokouhi; Legha Lotfollahi; Masoud Mardani; Maryam Haghighi-Morad; Amir Ahmad Nassiri; Davoud Rangraz; Hassan Falahaty; Hosein Syami; Yaghoob Irannejad; Maryam Fallah; Masoud Zangi; Navid Shafigh
Journal:  Blood Purif       Date:  2022-05-17       Impact factor: 3.348

4.  Predicting Risk Score for Mechanical Ventilation in Hospitalized Adult Patients Suffering from COVID-19.

Authors:  Samira Kafan; Kiana Tadbir Vajargah; Mehrdad Sheikhvatan; Gholamreza Tabrizi; Ahmad Salimzadeh; Mahnaz Montazeri; Fazeleh Majidi; Negin Maghuli; Marzieh Pazoki
Journal:  Anesth Pain Med       Date:  2021-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.